Compounds > 1,2-distearoyllecithin
Page last updated: 2024-08-24

1,2-distearoyllecithin and Adenocarcinoma

1,2-distearoyllecithin has been researched along with Adenocarcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Diakova, GB; Du, Z; Klibanov, AL1
Brockman, JD; Hawthorne, MF; Jalisatgi, SS; Khan, AA; Kueffer, PJ; Maitz, CA; Nigg, DW; Schuster, SA; Shlyakhtina, NI1
Diakova, GB; Herbst, EB; Hossack, JA; Klibanov, AL; Mauldin, FW; Wang, S1
Benazzouz, F; Cordobes, MD; de Beco, V; Moretti, JL; Starzec, A1

Other Studies

4 other study(ies) available for 1,2-distearoyllecithin and Adenocarcinoma

ArticleYear
Targeted Ultrasound Contrast Imaging of Tumor Vasculature With Positively Charged Microbubbles.
    Investigative radiology, 2020, Volume: 55, Issue:11

    Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Contrast Media; Mice; Mice, Inbred C57BL; Microbubbles; Phosphatidylcholines; Polyethylene Glycols; Ultrasonography

2020
Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Apr-16, Volume: 110, Issue:16

    Topics: Adenocarcinoma; Animals; Boranes; Boron Neutron Capture Therapy; Female; Kaplan-Meier Estimate; Liposomes; Mammary Neoplasms, Experimental; Mice; Phosphatidylcholines; Time Factors; Treatment Outcome

2013
Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?
    Investigative radiology, 2016, Volume: 51, Issue:12

    Topics: Adenocarcinoma; Animals; Contrast Media; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Microbubbles; Molecular Imaging; Neovascularization, Pathologic; Phosphatidylcholines; Ultrasonography; Vascular Endothelial Growth Factor Receptor-2

2016
Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
    Nuclear medicine communications, 1999, Volume: 20, Issue:5

    Topics: Adenocarcinoma; Biological Transport; Breast Neoplasms; Carcinoma, Small Cell; Cholesterol; Drug Resistance, Multiple; Female; Humans; Kinetics; Liposomes; Lung Neoplasms; Mouth Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured

1999